FDA Approves Pioneering Cancer Treatment With $475000 Price Tag – Wall Street Journal (subscription)
Wall Street Journal (subscription) |
FDA Approves Pioneering Cancer Treatment With $475000 Price Tag
Wall Street Journal (subscription) The Food and Drug Administration approved a first-of-its kind cancer therapy aimed at bolstering a patient's own immune cells, while the drugmaker behind the treatment attempted to allay worry over the high cost of the procedure. Swiss pharmaceuticals … |
